Livestock Genetics and Animal Breeding Technology: Industry Landscape
The global animal genetics market reached $7.4 billion in 2024 and is projected to surpass $13 billion by 2033, driven by advances in genomic selection, CRISPR gene editing, and precision reproductive technologies. The sector spans everything from traditional artificial insemination cooperatives to venture-backed startups deploying AI-driven genomic analytics.
Key Technology Segments
- Genomic Selection & Testing
- Next-generation sequencing (NGS) and SNP genotyping enable breeders to calculate Estimated Breeding Values (EBVs) from DNA alone, dramatically accelerating genetic gain. Neogen's Lincoln, NE facility processes tens of thousands of animal DNA samples daily — the world's largest genotyping operation.
- Reproductive Technologies
- In vitro fertilization (IVF), embryo transfer, and sexed semen allow producers to multiply elite genetics at scale. Trans Ova Genetics, a subsidiary of URUS Group, recently expanded its bovine IVF capabilities to Australia through a partnership with TLG.
- Gene Editing & CRISPR
- Companies like Genus plc are applying CRISPR to develop disease-resistant livestock — notably pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS), a disease costing the U.S. pork industry an estimated $664 million annually.
- Precision Livestock Analytics
- Startups like Vytelle combine individual feed intake and weight data with AI-driven analytics to optimize genetic selection decisions, reporting 278% revenue growth as ranchers adopt data-driven herd management.
Market Structure
The industry features a mix of large vertically-integrated groups and specialist firms. URUS Group, formed in 2018 from a unique cooperative-private merger, distributes 32 million units of semen annually through its subsidiaries including Alta Genetics, GENEX, and Trans Ova Genetics. Genus plc, publicly listed on the London Stock Exchange, generated approximately £669 million in revenue (FY2024) through its ABS (bovine) and PIC (porcine) divisions.
Multi-species breeders like Hendrix Genetics — backed by Paine Schwartz Partners — operate across layers, turkeys, swine, salmon, shrimp, and trout, reflecting the sector's expansion beyond traditional cattle genetics into aquaculture and poultry genomics.
Investment & Consolidation Trends
M&A activity continues to reshape the landscape. Key recent moves include Trans Ova Genetics' acquisition of ReproLogix in 2025 and Neogen's launch of Igenity BCHF, the first genomic test for bovine congestive heart failure risk. Government programs such as USDA NIFA grants for Animal Breeding, Genetics, and Genomics further fuel R&D across the sector.